<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01883856</url>
  </required_header>
  <id_info>
    <org_study_id>16051</org_study_id>
    <nct_id>NCT01883856</nct_id>
  </id_info>
  <brief_title>Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves</brief_title>
  <official_title>Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New World Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and compare the clinical outcomes after implantation
      of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the silicone plate
      Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate and compare the clinical outcomes after implantation
      of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the silicone plate
      Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma. Participation will
      last for 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Intraocular Pressure</measure>
    <time_frame>12 months</time_frame>
    <description>The primary endpoint is the mean intraocular pressure in the porous plate group as compared to the silicone plate group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anti-Glaucoma Medications</measure>
    <time_frame>12 months</time_frame>
    <description>The mean number of anti-glaucoma medications in the porous plate group as compared to the silicone plate group at 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Success</measure>
    <time_frame>12 months</time_frame>
    <description>Surgical success in the porous plate group as compared to the silicone plate group at 12 months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Silicone Plate Ahmed Glaucoma Valve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Silicone plate Ahmed Glaucoma Valve</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Porous Plate Ahmed Glaucoma Valve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Porous Plate Ahmed Glaucoma Valve</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silicone plate Ahmed Glaucoma Valve (Model FP7)</intervention_name>
    <description>This intervention is conducted as a surgical intervention.</description>
    <arm_group_label>Silicone Plate Ahmed Glaucoma Valve</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Porous Plate Ahmed Glaucoma Valve (Model M4)</intervention_name>
    <description>This intervention is conducted as a surgical intervention.</description>
    <arm_group_label>Porous Plate Ahmed Glaucoma Valve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female of any race ≥ 18 years and ≤ 80 years of age.

          -  Diagnosis of intractable glaucoma in the study eye, with the exception of silicone oil
             endotamponade induced glaucoma, which has not responded to conventional medical and
             surgical therapy.

          -  Elevated intraocular pressure &gt; 21 mmHg in the study eye. Two consecutive measurements
             using Goldmann Applanation Tonometry will be obtained and the mean of those two
             measurements will be considered the subject's baseline intraocular pressure.

          -  Subject is a candidate for surgery in the study eye with a glaucoma drainage device.

          -  Subject is willing and able to sign the informed consent.

        Exclusion Criteria:

          -  Diagnosis of silicone oil endotamponade induced glaucoma in the study eye.

          -  History of prior drainage implant surgery in the study eye.

          -  History of cyclophotocoagulation of the study eye.

          -  Pregnancy.

          -  Prisoner.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter A Netland, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter A Netland, MD, PhD</last_name>
    <phone>(434) 243-2852</phone>
    <email>klh7v@virginia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristina Holbrook</last_name>
    <phone>(434) 243-2852</phone>
    <email>klh7v@virginia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Holbrook</last_name>
      <phone>434-243-2852</phone>
      <email>klh7v@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Peter A Netland, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2013</study_first_submitted>
  <study_first_submitted_qc>June 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2013</study_first_posted>
  <last_update_submitted>December 15, 2014</last_update_submitted>
  <last_update_submitted_qc>December 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Refractory Glaucoma</keyword>
  <keyword>Intractable Glaucoma</keyword>
  <keyword>Primary Open Angle Glaucoma</keyword>
  <keyword>Neovascular Glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

